The present invention relates to novel compounds selected from 2-(3substitutedaryl)amino-4-aryl-thiazoles that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
本发明涉及从2-(3取代芳基)
氨基-4-芳基
噻唑中选择的新化合物,其选择性地调节、调控和/或抑制某些与多种人类和动物疾病有关的本地和/或突变的
酪氨酸激酶介导的
信号转导,例如细胞增殖、代谢、过敏和退行性疾病。更具体地说,这些化合物是有效的、选择性的c-kit
抑制剂。